Review. Acridine orange could be an innovative anticancer agent under photon energy.

Acridine orange (AO) was extracted as a dye from coal tar over a hundred years ago. It has various unique biological activities and has been shown to be a useful fluorescent dye specific for DNA and RNA, a pH indicator, photosensitizer, antitumor and antimalarial drug, and detector of bacteria and parasites. It has recently been found that AO accumulates in musculoskeletal sarcomas and that after illumination of the tumors with visible light or irradiation with low-dose X-rays, the dye rapidly exerts selective cytocidal effect against the sarcoma cells. Therefore, surgery combined with photo- (PDT) or radiodynamic therapy (RDT) with AO (AO-PDT and -RDT) has been applied to human musculoskeletal sarcomas. The results of a clinical study on the outcome of this therapeutic strategy revealed that it yielded better local control and remarkably better limb function than wide resectional surgery. Based on our experimental studies, it was clarified that AO accumulates in acidic organelles or structures, especially lysosomes, depending on the acidity. An enormous number of protons are produced in cancer from lactate or CO2 under hypoxic conditions, which are moved into the extracellular fluid or lysosomes to maintain the intracellularfluid pH. Therefore, AO shows marked accumulation in the acidic lysosomes of cancer cells. Photon energy from visible light or X-rays excites the AO accumulated in lysosomes; the excited AO emits fluorescence and forms activated oxygen from intra-cytoplasmic oxygen. The activated oxygen destroys lysosomes, with the released lysosomal enzymes causing rapid death of the cancer cells. On the other hand, normal cells can exclude AO quickly because they are not acidic. Thus, AO-PDT and AO-RDT exhibit strong and selective cytocidal effect against malignant tumors. In conclusion, we believe that AO-PDT and AO-RDT exhibit selective anticancer cell activity and that AO excited by photon energy has excellent potential as an anticancer agent.

[1]  Joseph D. Smith,et al.  RAPID DIAGNOSIS OF MALARIA BY ACRIDINE ORANGE STAINING OF CENTRIFUGED PARASITES , 1989, The Lancet.

[2]  J. Buckwalter,et al.  Intrinsic radiation resistance in human chondrosarcoma cells. , 2006, Biochemical and biophysical research communications.

[3]  Y. Hirasawa,et al.  Photodynamic Inactivation with Acridine Orange on a Multidrug‐resistant Mouse Osteosarcoma Cell Line , 2000, Japanese journal of cancer research : Gann.

[4]  A. Zampieri,et al.  Mutagenesis by acridine orange and proflavine in Escherichia coli strain S. , 1965, Mutation research.

[5]  Y. Hirasawa,et al.  Fluorovisualization effect of acridine orange on mouse osteosarcoma. , 2000, Anticancer research.

[6]  T. Belyaeva,et al.  Acridine orange accumulation in acid organelles of normal and vacuolated frog skeletal muscle fibres , 2006, Cell biology international.

[7]  F. Volot,et al.  Recurrences following primary osteosarcoma in adolescents and adults previously treated with chemotherapy. , 2003, European journal of cancer.

[8]  F. Howe,et al.  Why are cancers acidic? A carrier-mediated diffusion model for H+ transport in the interstitial fluid. , 2001, Novartis Foundation symposium.

[9]  J. Amagasa.  Mechanisms of photodynamic inactivation of acridine orange-sensitized transfer RNA: participation of singlet oxygen and base damage leading to inactivation. , 1986, Journal of radiation research.

[10]  M. Gordon,et al.  The photodynamic inactivation of tobacco mosaic virus and its ribonucleic acid by acridine orange. , 1966, Biochimica et biophysica acta.

[11]  Y. Hirasawa,et al.  Intracellular binding sites of acridine orange in living osteosarcoma cells. , 2000, Anticancer research.

[12]  L. Ambrosone,et al.  Detection of microorganisms in clinical specimens using slides prestained with acridine orange (AOS). , 1989, Microbiologica.

[13]  P. Goland,et al.  IN VIVO STAINING AND RETARDATION OF TUMORS IN MICE BY ACRIDINE COMPOUNDS , 1948, The American journal of the medical sciences.

[14]  M. Ballo,et al.  Prognostic factors for patients with localized soft‐tissue sarcoma treated with conservation surgery and radiation therapy , 2003, Cancer.

[15]  A. Uchida,et al.  Acridine orange used for photodynamic therapy accumulates in malignant musculoskeletal tumors depending on pH gradient. , 2006, Anticancer research.

[16]  Yasusuke Hirasawa,et al.  Acridine Orange Excited by Low-Dose Radiation Has a Strong Cytocidal Effect on Mouse Osteosarcoma , 2002, Oncology.

[17]  Masashi Seto,et al.  Clinical trial of photodynamic therapy using acridine orange with/without low dose radiation as new limb salvage modality in musculoskeletal sarcomas. , 2005, Anticancer research.

[18]  A. Zelenin.  Fluorescence Microscopy of Lysosomes and Related Structures in Living Cells , 1966, Nature.

[19]  U. Brunk,et al.  PHOTOOXIDATIVE DAMAGE TO LYSOSOMES OF CULTURED MACROPHAGES BY ACRIDINE ORANGE , 1990, Photochemistry and photobiology.

[20]  Yasusuke Hirasawa,et al.  Total Tumor Cell Elimination with Minimum Damage to Normal Tissues in Musculoskeletal Sarcomas following Photodynamic Therapy with Acridine Orange , 2000, Oncology.

[21]  B. Ames,et al.  Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Tayyaba Hasan,et al.  Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity. , 2003, Cancer research.

[23]  T. Kawakami,et al.  Vesicle disruption, plasma membrane bleb formation, and acute cell death caused by illumination with blue light in acridine orange-loaded malignant melanoma cells. , 2007, Journal of photochemistry and photobiology. B, Biology.

[24]  G. Snow,et al.  Basic principles, applications in oncology and improved selectivity of photodynamic therapy. , 2003, Anticancer research.

[25]  M. Melamed,et al.  Interactions of acridine orange with nucleic acids. Properties of complexes of acridine orange with single stranded ribonucleic acid. , 1983, Biochemical pharmacology.

[26]  K. Korgaonkar,et al.  Anti-Tumour Activity of the Fluorescent Dye, Acridine Orange, on Yoshida Sarcoma (Ascites) , 1963, British Journal of Cancer.

[27]  M. Manfait,et al.  Characterization of Acidic Vesicles in Multidrug-resistant and Sensitive Cancer Cells by Acridine Orange Staining and Confocal Microspectrofluorometry , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.